Jaguar Health confirms 2025 note fully retired, updates outstanding share count to 1,463,958

Jaguar Health, Inc. filed a second 8-K describing the same September 23, 2026 exchange transactions with Streeterville Capital, LLC, adding detail on the termination of one of the two notes involved and updating the Company's share count.

On September 23, 2026, the Company entered into privately negotiated exchange agreements with Streeterville, pursuant to which it issued an aggregate of 182,091 shares of common stock to Streeterville in exchange for a $1,678,320 reduction in the outstanding balance of the 2021 Note.¹ That note originated when on January 19, 2021, Jaguar Health issued and sold to Streeterville a secured promissory note in the original principal amount of $6,220,812.50 pursuant to a Note Purchase Agreement between the same parties dated as of the even date.¹

The filing also addresses termination of a separate note. As previously disclosed, on September 23, 2026, the Company entered into exchange agreements with Streeterville under which it issued an aggregate of 547,898 shares of common stock in exchange for a $5,049,909.26 reduction in the outstanding balance of a secured promissory note in the original principal amount of $10,810,000 issued on November 12, 2025, and upon completion of that transaction, the 2025 Note was fully paid and cancelled.¹

On registration, the 2021 Note Exchange Shares were issued in reliance on the exemption from registration provided under Section 3(a)(9) of the Securities Act of 1933, as amended.¹

As of September 24, 2026, the Company had approximately 1,463,958 shares of Common Stock issued and outstanding.¹ The report was signed by Lisa A. Conte, President and Chief Executive Officer, on September 24, 2026.¹